U.S. FDA Agrees to Review Talazoparib for Advanced and Triple Negative Breast Cancer for Treatment of Patients with an Inherited BRCA Mutation

(June 21, 2018)

The U.S. Food and Drug Administration accepted for filing and granted Priority Review designation for Pfizer’s New Drug Application for talazoparib. The submission is based on results from the EMBRACA trial, which compared talazoparib to chemotherapy... Continue Reading


Comparison of Aromatase Inhibitors Expands Treatment Options for Women Requiring Hormonal Therapy for Early Stage Breast Cancer

(April 19, 2018)

CancerConnect News: According to an Italian research team the three aromatase inhibitors approved for the treatment of postmenopausal hormone receptor–positive early stage breast cancer have no significant differences in effectiveness or safety, For... Continue Reading


FDA Approves Perjecta for Adjuvant Treatment of HER2-positive Breast Cancer

(March 26, 2018)

CancerConnect News: On December 20, 2017, the Food and Drug Administration granted regular approval to Perjeta (pertuzumab) for use in combination with Herceptin (trastuzumab) and chemotherapy as adjuvant treatment of patients with HER2-positive early... Continue Reading


At-home Genetic Testing may be Convenient, but it isn’t Complete

(March 20, 2018)

March 14, 2018 https://www.statnews.com/2018/03/14/genetic-testing-23andme-brca/   Home delivery for everything from fresh produce to custom-selected clothing has become a way of life for many Americans. While most home-delivery conveniences are generally... Continue Reading


FDA Approval for Verzenio™ as Initial Treatment for Advanced Breast Cancer

(March 12, 2018)

CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved VerzenioTM (abemaciclib) in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor-positive... Continue Reading


Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

(February 21, 2018)

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to new research published by a multi-institutional... Continue Reading


Kisqali Combination Promising for Pre-menopausal Hormone Receptor Positive Breast Cancer

(February 13, 2018)

CancerConnect News: The CDK4/6 inhibitor Kisqali (ribociclib) has been given breakthrough status by the US Food and Drug Administration as an initial endocrine-based treatment for of pre- or perimenopausal women with hormone-receptor positive, human epidermal... Continue Reading


Five Common Sign & Symptoms of Breast Cancer

(February 12, 2018)

CancerConnect News: Breast cancer is a cancer that originates in the area of the breast, where cells replicate too quickly, causing a tumor. Breast cancer is most common in women, but I can also occur in men. Breast cancer is caused by an abnormality... Continue Reading


Breast Cancer Treatments May Increase Risk of Heart Disease

(February 5, 2018)

American Heart Association Scientific Statement Statement Highlights: Some breast cancer therapies can damage the heart and healthcare providers should carefully monitor breast cancer treatment effects on the heart. Breast cancer survivors, especially... Continue Reading


Lynparza Slows Spread of Inherited Breast Cancer Caused by BRCA Mutations: First Drug Approved for BRCA Breast Cancer

(January 15, 2018)

CancerConnect News: The US Food and Drug Administration (FDA) has extended the approval of Lynparza (olaparib) to include the treatment of metastatic breast cancer in patients who carry the specific inherited BRCA mutation.  These patients can be identified... Continue Reading


Latest Breast Cancer News By Stage


Carcinoma In Situ Breast cancer

Sorry, there are no articles available for this cancer stage.

More Carcinoma In Situ Breast cancer

Inflammatory Breast Cancer

Sorry, there are no articles available for this cancer stage.

More Inflammatory Breast Cancer

Metastatic Breast Cancer

FDA approves new treatment for certain advanced or metastatic breast cancers

(October 5, 2017)

The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed... Continue Reading


More Metastatic Breast Cancer

Recurrent Breast Cancer

Sorry, there are no articles available for this cancer stage.

More Recurrent Breast Cancer

Screening/Prevention Breast Cancer

Sorry, there are no articles available for this cancer stage.

More Screening/Prevention Breast Cancer

Stage I Node Negative Breast Cancer

Sorry, there are no articles available for this cancer stage.

More Stage I Node Negative Breast Cancer

Stages II-III Breast Cancer

Sorry, there are no articles available for this cancer stage.

More Stages II-III Breast Cancer

Supportive Care Breast Cancer

Sorry, there are no articles available for this cancer stage.

More Supportive Care Breast Cancer